Tenaya Therapeutics Inc.
Organization details
- Legal name
- Tenaya Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- South SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TNYA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001858848
- EIN
- 81-3789973
Board of directors
-
Amy L. Burroughs · DirectorSince 2023
-
Catherine Stehman-Breen · DirectorSince 2023
-
David Goeddel V · DirectorSince 2023
-
Deepak Srivastava · DirectorSince 2023
-
Faraz Ali · Director · Chief Executive OfficerSince 2023
-
Jeffrey T. Walsh · DirectorSince 2023
-
Jin-Long Chen · DirectorSince 2023
-
June Lee · DirectorSince 2023
-
Karah Herdman Parschauer · DirectorSince 2023
-
R. Sanders Williams · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.5%
-
96.5%
-
96.7%
Board connections
5 of this board's directors also sit on 6 other boards. 6 are in the same sector.
-
Amgen Inc. Same sectorvia R. Sanders Williams
-
DiaMedica Therapeutics Inc. Same sectorvia Amy L. Burroughs
-
Dyne Therapeutics Inc. Same sectorvia Catherine Stehman-Breen
-
Eledon Pharmaceuticals Inc. Same sectorvia June Lee
-
Evolus Inc. Same sectorvia Karah Herdman Parschauer
-
Labcorp Holdings Inc. Same sectorvia R. Sanders Williams
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $5,970,460
- 35 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | Faraz Ali Director, Officer (Chief Executive Officer) | Grant or award | +122,000 | — | — |
| Sep 10, 2026 | Tingley Whittemore Officer (Chief Medical Officer) | Grant or award | +49,000 | — | — |
| Aug 17, 2026 | Faraz Ali Director, Officer (Chief Executive Officer) | Open-market sale | −5,837 | $0.71 | $4,144 |
| Aug 17, 2026 | Tingley Whittemore Officer (Chief Medical Officer) | Open-market sale | −1,637 | $0.71 | $1,162 |
| Aug 17, 2026 | Faraz Ali Director, Officer (Chief Executive Officer) | Open-market sale | −3,969 | $0.71 | $2,818 |
| Aug 17, 2026 | Tingley Whittemore Officer (Chief Medical Officer) | Open-market sale | −1,637 | $0.71 | $1,162 |
| Aug 17, 2026 | Faraz Ali Director, Officer (Chief Executive Officer) | Open-market sale | −5,020 | $0.71 | $3,564 |
| Aug 17, 2026 | Tingley Whittemore Officer (Chief Medical Officer) | Open-market sale | −1,871 | $0.71 | $1,328 |
| Aug 17, 2026 | Faraz Ali Director, Officer (Chief Executive Officer) | Open-market sale | −7,406 | $0.71 | $5,258 |
| Aug 17, 2026 | Tingley Whittemore Officer (Chief Medical Officer) | Open-market sale | −2,279 | $0.71 | $1,618 |
| May 18, 2026 | Faraz Ali Director, Officer (Chief Executive Officer) | Open-market sale | −3,390 | $0.79 | $2,678 |
| May 18, 2026 | Tingley Whittemore Officer (Chief Medical Officer) | Open-market sale | −3,121 | $0.79 | $2,466 |
| May 18, 2026 | Higa Tomohiro Officer (SVP, Finance) | Open-market sale | −1,485 | $0.79 | $1,173 |
| Feb 25, 2026 | TCG Opportunity III GP, LLC 10% owner | Open-market sale | −1,649,281 | $0.56 | $923,597 |
| Feb 25, 2026 | TCG Opportunity III GP, LLC 10% owner | Open-market sale | −1,862,545 | $0.56 | $1,043,025 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Tenaya Therapeutics Inc.
Who is the CEO of Tenaya Therapeutics Inc.?
Faraz Ali is Tenaya Therapeutics Inc.'s Chief Executive Officer.
How many directors are on Tenaya Therapeutics Inc.'s board?
Tenaya Therapeutics Inc.'s board has 10 directors: Amy L. Burroughs, Catherine Stehman-Breen, David Goeddel V, Deepak Srivastava, Faraz Ali, Jeffrey T. Walsh, Jin-Long Chen, June Lee, Karah Herdman Parschauer and R. Sanders Williams.
Are Tenaya Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Tenaya Therapeutics Inc. insiders made no open-market purchases and sold $6.0 million of shares in 35 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tenaya-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.